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In our search for novel biocatalysts for the synthesis of nucleic acid derivatives,
we found a good candidate in a putative dual-domain hypoxanthine-guanine
phosphoribosyltransferase (HGPRT)/adenylate kinase (AMPK) from Zobellia
galactanivorans (ZgHGPRT/AMPK). In this respect, we report for the first time
the recombinant expression, production, and characterization of a bifunctional
HGPRT/AMPK. Biochemical characterization of the recombinant protein indicates
that the enzyme is a homodimer, with high activity in the pH range 6-7 and in a
temperature interval from 30 to 80◦C. Thermal denaturation experiments revealed
that ZgHGPRT/AMPK exhibits an apparent unfolding temperature (Tm) of 45◦C and a
retained activity of around 80% when incubated at 40◦C for 240 min. This bifunctional
enzyme shows a dependence on divalent cations, with a remarkable preference for
Mg2+ and Co2+ as cofactors. More interestingly, substrate specificity studies revealed
ZgHGPRT/AMPK as a bifunctional enzyme, which acts as phosphoribosyltransferase
or adenylate kinase depending upon the nature of the substrate. Finally, to assess the
potential of ZgHGPRT/AMPK as biocatalyst for the synthesis of nucleoside-5′-mono,
di- and triphosphates, the kinetic analysis of both activities (phosphoribosyltransferase
and adenylate kinase) and the effect of water-miscible solvents on enzyme activity
were studied.
Keywords: enzymatic synthesis, nucleotides, phosphoribosyltransferase, nucleoside-5′-monophosphate kinase,
dual domain protein
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INTRODUCTION
Purine nucleotides are involved in multitude of biochemical
processes, but they are also particularly important as building
blocks for RNA and DNA synthesis. Biosynthesis of purine
nucleotides is performed through two different metabolic
routes, de novo and salvage pathways. In the de novo
pathway, purine nucleotides are synthesized from simple
precursors like glycine, glutamine, or aspartate. In contrast,
salvage pathway employs purine nucleobases to generate the
corresponding nucleoside-5′-monophosphates (NMPs). This
requirement for purines is satisfied by means of different
endogenous and/or exogenous sources of preformed nitrogen
bases (el Kouni, 2003; Del Arco and Fernández-Lucas, 2018).
Both metabolic routes, de novo and salvage pathways, lead to
inosine-5′-monophosphate (IMP) synthesis. IMP is converted
to guanosine-5′-monophosphate (GMP) and adenosine-5′-
monophosphate (AMP), which are subsequently phosphorylated
to get guanosine-5′-triphosphate (GTP) and adenosine-5′-
triphosphate (ATP), respectively.
Biocatalysis aims to reproduce, implement and expand
nature’s synthetic strategies to perform the synthesis of different
organic compounds using whole cells or enzymes.
The chemical synthesis of nucleotides proceeds through
the mono-, di-or triphosphorylation of precursor nucleosides.
However, chemical methodologies require the use of chemical
reagents (phosphoryl chloride, POCl3, or phosphorus pentoxide,
P2O5), acidic conditions, and organic solvents, which are
expensive and environmentally harmful (Yoshikawa et al.,
1967, 1969). In addition, chemical synthesis of the precursor
nucleosides requires the protection and de-protection of
functional groups, as well as the isolation of intermediates.
It leads to poor or moderate global yields and low product
purity, and therefore an increase in production costs. In contrast,
enzymatic bioprocesses offers many different advantages, such
as the possibility of one-pot reactions under mild conditions,
high chemo-, regio- and stereoselectivity, and an eco-friendly
technology (Del Arco and Fernández-Lucas, 2017; Acosta et al.,
2018; Del Arco et al., 2018b).
In this sense, the use of enzymes from purine and pyrimidine
salvage pathway as biocatalysts for the synthesis of nucleosides
and nucleotides has been extensively reported (Mikhailopulo,
2007; Fernández-Lucas et al., 2010; Fresco-Taboada et al., 2013;
Fernández-Lucas, 2015; Lapponi et al., 2016; Del Arco and
Fernández-Lucas, 2017; Ding and Ou, 2017; Lewkowicz and
Iribarren, 2017; Serra et al., 2017; Acosta et al., 2018; Del Arco
et al., 2018b, 2019a; Pérez et al., 2018; Kamel et al., 2019; Ubiali
and Speranza, 2019).
6-oxopurine phosphoribosyltransferases (6-oxo PRTs, EC
2.4.2.8, EC 2.4.2.22) are essential enzymes in the purine salvage
pathway (el Kouni, 2003). 6-oxo PRTs catalyze the reversible
transfer of the 5-phosphoribosyl group from 5-phospho-α-D-
ribosyl-1-pyrophosphate (PRPP) to N9 on the 6-oxopurine bases
hypoxanthine (1), guanine (2) or xanthine (3) to form IMP (4),
GMP (5) or XMP (6) (HPRT, GPRT, XPRT, HGPRT, GXPRT or
HGXPRT), respectively, in the presence of Mg2+ (Del Arco et al.,
2017, 2018c; Figure 1A).
Adenylate kinase (EC 2.7.4.3, AMPK) belongs to nucleoside-
5′-monophosphate kinase (NMPK) family. AMPK catalyzes the
reversible transfer of the terminal phosphate group between ATP
and AMP to give 2 molecules of ADP in presence of Mg2+
(Figure 1B). AMPK is present in de novo synthesis of nucleotides
and also plays an essential role in the maintenance of cellular
homeostasis of adenine nucleotides by the interconversion of
AMP, ADP and ATP (Davlieva and Shamoo, 2010; Panayiotou
et al., 2014).
Herein we report, for the first time, a bifunctional protein
from Zobellia galactanivorans which contains both HGPRT (N-
terminal part) and AMPK (C-terminal part) domains (Figure 2).
In the N-terminal part a HGPRT module, involved in the
purine salvage, converts Hyp to IMP and Gua to GMP.
Also, in the C-terminal part an AMPK module, involved in
the energy metabolism and nucleotide synthesis, catalyzes the
reversible transfer of the terminal phosphate group from ATP
to AMP. The recombinant protein (named ZgHGPRT/AMPK)
was shown as a homodimer, active in the pH interval 6-
7 and in a broad temperature range (30–80◦C). Moreover,
ZgHGPRT/AMPK displays an apparent unfolding temperature
(Tm) of 45◦C. Finally, to assess the potential ofZgHGPRT/AMPK
the kinetic analysis of both activities (phosphoribosyltransferase
and adenylate kinase) and the effect of divalent cations and
water-miscible solvents on enzyme activity were assayed.
MATERIALS AND METHODS
Materials
Cell culture medium reagents were purchased from Difco (St.
Louis, MO, United States). Triethyl ammonium acetate buffer
was provided by Sigma-Aldrich (Madrid, Spain). All other
reagents and organic solvents were purchased from Symta
(Madrid, Spain). Nucleosides, nucleotides and nucleobases were
provided by Carbosynth Ltd. (Compton, United Kingdom).
Cloning, Expression and Protein
Purification
After an in silico mining of phosphoribosyltransferase (PRT)
candidates, we found a gene which encodes a putative
bifunctional protein HGPRT/AMPK in Zobellia galactanivorans
genome (European Nucleotide Archive code: CAZ96627;
UniProtKB code G0LC40). The corresponding hgprt/ampk
gene was provided by GenScript (United States) as a NheI-
BamHI fragment subcloned into the expression vector pET28b
(+). The recombinant vector pET28bZgHGPRT/AMPK encodes
an N-terminal His6-tagged fusion with a thrombin cleavage
site between the tag and the enzyme. ZgHGPRT/AMPK was
expressed in Escherichia coli BL21(DE3) grown at 37◦C in Luria
Bertani medium supplemented with kanamycin (50 µg/mL).
Protein overexpression was induced by adding 0.5 mM isopropyl
β-D-1-thiogalactopyranoside (IPTG) to exponential cultures
and the cells were further grown for 4 h. Then, cells were
harvested by centrifugation at 3,800 × g and the resulting
pellet was resuspended in 10 mM sodium phosphate buffer
pH 7. Crude extracts were prepared by cellular disruption of
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FIGURE 1 | (A) Enzymatic synthesis of 6-oxopurine purine nucleosides monophosphate catalyzed by 6-oxopurine PRTs. (B) Enzymatic synthesis adenine
nucleotides catalyzed by AMPKs.
FIGURE 2 | Cartoon representation of the ZgHGPRT/AMPK monomer model comprising HGPRT (yellow) and AMPK (green) domains. The figure was prepared with
PyMOL (Delano, 2002).
cell suspensions using a digital sonicator. The lysates were
centrifuged at 16,500 × g for 30 min at 4◦C. The cleared
lysates were loaded onto a 5-mL HisTrap FF column (GE
Healthcare), pre-equilibrated in a binding buffer (20 mM
Tris–HCl buffer, pH 7.5, with 100 mM NaCl and 20 mM
imidazole). Bound proteins were eluted using a linear gradient
of imidazole (from 20 to 500 mM). Fractions containing
ZgHGPRT/AMPK were identified by SDS-PAGE, pooled,
concentrated and loaded onto a HiLoad 16/60 Superdex 200
prep grade column (GE Healthcare) pre-equilibrated in 20 mM
sodium phosphate, pH 7. Fractions with the protein of interest
were identified by SDS-PAGE. Protein concentration was
determined spectrophotometrically by UV absorption 280 nm
using a ε280 = 22,350 M−1cm−1.
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Analytical Ultracentrifugation Analysis
Sedimentation velocity experiments for ZgHGPRT/AMPK were
carried out in 20 mM Tris–HCl (pH 8, 20◦C, 50,000 × g)
using an Optima XL-I analytical ultracentrifuge (Beckman-
Coulter Inc.) equipped with UV-VIS absorbance and Raleigh
interference detection systems, an An-60Ti rotor and standard
(12 mm optical path) double-sector center pieces of Epon-
charcoal. Sedimentation profiles were recorded at 292 nm.
Sedimentation coefficient distributions were calculated by least-
squares boundary modeling of sedimentation velocity using
the continuous distribution c(s) Lamm equation model as
implemented by SEDFIT 14.7 g.
Baseline offsets were measured afterward at 200,000 × g.
The apparent sedimentation coefficient distribution, c(s),
and sedimentation coefficients were calculated from the
sedimentation velocity data using SEDFIT (Brown and Schuck,
2006). The experimental sedimentation coefficients were
corrected to standard conditions (water, 20◦C, and infinite
dilution) using SEDNTERP software to obtain the corresponding
standard values (s20,w) (Laue et al., 1992). The corresponding
apparent weight-average molar masses (Mw) were determined
from the buoyant masses, considering the partial specific
volumes of the protein (0.4 mg/ml) obtained from the amino
acid composition using the program SEDNTERP (Minton, 1997).
Phosphoribosyltransferase Activity
Assay
The standard phosphoribosyltransferase activity assay was
performed by incubating 10–50 µL of free extracts or 6.5–13 µg
of purified enzyme with a 40 µL solution containing 2 mM PRPP,
2 mM Hyp, 2.4 mM MgCl2 in 50 mM Tris–HCl pH 8 at 50◦C and
300 r.p.m. for 5–10 min After this, the enzyme was inactivated
as previously described (Del Arco et al., 2018a) and the IMP
production was analyzed and quantitatively measured using
HPLC. All determinations were carried out in triplicate and the
maximum error was ≤2%. Under such conditions, one activity
unit, U (µmol/min), was defined as the amount of enzyme (mg)
producing 1 µmol/min of IMP under the assay conditions.
Influence of pH and Temperature on
ZgHGPRT/AMPK Activity
The optimum pH of the enzyme was determined under standard
phosphoribosyltransferase assay condition, using sodium citrate
(pH 4–6), sodium phosphate (pH 6–8.5), MES (pH 5.5–7), Tris–
HCl (pH 7–9) and sodium borate (pH 8–11) as reaction buffers
(50 mM). The optimum temperature was determined using the
standard assay over a 20–80◦C range.
Influence of Divalent Cations on Enzyme
Activity
To determine the effect of divalent cations on ZgHGPRT/AMPK
activity, different divalent salts (MgSO4, MnSO4, ZnSO4, CoSO4,
and CaCl2) were added to the reaction mixture at different
concentrations (2–20 mM). The reaction was performed using
the standard phosphoribosyltransferase activity assay under the
optimal pH and temperature conditions previously determined.
In this respect, 6.5 µg of purified enzyme were incubated in a
40 µL solution containing with 2 mM PRPP, 2 mM Hyp and 2–
20 mM divalent salts, in 50 mM sodium phosphate buffer pH 7 at
50◦C and 300 r.p.m., 5–10 min.
Influence of Water-Miscible Solvents on
Enzyme Activity
To determine the effect of organic solvents on enzymatic
activity, the phosphoribosyltransferase activity was assayed in
the presence of different protic and aprotic organic solvents.
To this end, 6.5 µg of purified enzyme were added to a 40 µL
solution containing 2 mM PRPP, 2 mM Hyp, 2.4 mM MgCl2 in
50 mM sodium phosphate buffer pH 7, in the presence of 20%
(v/v) water-miscible organic solvents. The reaction mixture was
incubated at 50◦C for 5–10 min (300 r.p.m.).
Thermal Stability
ZgHGPRT/AMPK was stored at 4 and −80◦C in 20 mM sodium
phosphate buffer, pH 7 for 365 days. Periodically, samples were
taken and the enzymatic activity was evaluated. Storage stability
was defined as the relative activity between the first and the
successive reactions. Moreover, thermal stability was studied
by incubating 6.5 µg of purified enzyme in 20 mM sodium
phosphate buffer, pH 7, for 240 min at different temperatures
(40–60◦C).
Thermal Denaturation
The melting temperature (Tm) was measured using differential
scanning fluorimetry in a Rotor GeneTM 6000 (Corbett Life
Sciences) essentially as previously described (Niesen et al., 2007;
Del Arco et al., 2019b). For this purpose, ZgHGPRT/AMPK was
diluted to a final concentration of 20 and 18 µL were mixed with
2 µL 100× diluted SYPRO Orange (Sigma-Aldrich, St. Louis,
MO, United States). The samples were heated over 35–95◦C
range at 1◦C/min. The fluorescent signal was measured with
excitation and emission filters of 460 and 510 nm, respectively.
TheTm was approximated to the melt peak obtained from a graph
plotting the negative first derivative of the melting curve with
respect to the temperature (dRFU/dT vs. T), where RFU stands
for relative fluorescence units.
Substrate Specificity
To assess the potential of ZgHGPRT/AMPK as a bifunctional
catalyst, both phosphoribosyltransferase and adenilate kinase
activities were assayed.
On the one hand the phosphoribosyltransferase activity
of ZgHGPRT/AMPK was tested against different purine and
pyrimidine nucleobases at different conditions. In this respect,
50 mM sodium phosphate buffer pH 7 was used as reaction buffer
when hypoxanthine, adenine, cytosine, uracil or thymine were
used as substrates, whereas 50 mM Tris–HCl buffer pH 8 was
used as reaction buffer for guanine and xanthine.
One the other hand, the interconversion of adenine
nucleotides (ATP, ADP, and AMP) was assayed to evaluate
adenylate kinase activity. To this end, 13 µg of purified enzyme
were added to a 40 µL solution containing 3.2 mM ATP and
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FIGURE 3 | Cartoon representation of the overall ZgHGPRT/AMPK model, comprising both subunits (green and blue). The figure was prepared with PyMOL (Delano,
2002).
3.2 mM AMP (or 6.4 mM ADP), 12 mM MgCl2 in 50 mM
sodium phosphate buffer pH 7. The reaction mixture was
incubated at 50◦C and 300 r.p.m. for 10–20 min.
Kinetic Analysis
The steady-state kinetic parameters, KM, kcat, and kcat/KM,
for both HGPRTase and AMPKase activities were determined.
The kinetic analysis of HGPRT was performed at varying
concentrations of one substrate (0.5–17.2 mM for Hyp, 0.5–
17.2 mM for PRPP), fixing the concentration of the other
substrate at constant saturating level (5 mM). An identical
approach was followed for the kinetic analysis of AMPKase
activity (0.5–10 mM for AMP, 0.5–10 mM for ATP) using 3.2 mM
as constant saturation concentration. Apparent KM, kcat, and
kcat/KM, were determined by non-linear regression assuming
Michaelis–Menten kinetics. Calculations were carried out using
the GraphPad Prism 8 (Motulsky and Christopoulos, 2019).
Homology Modeling
In order to analyze the structural features of ZgHGPRT/AMPK
a 3D homology model of the enzyme was built. First, the
single domain homology models were built by employing
Swiss-Model server (Waterhouse et al., 2018), using the best
protein templates of known 3D structures for each domain.
Thus, HGPRT from Leptospira interrogans (PDB id 4QRI)
and AMPK structure from Geobacillus stearothermophilus (PDB
id 1ZIN) were selected as templates. Then, a complete
ZgHGPRT/AMPK 3D model was built through assembling the
best homology models for both, HGPRT and AMPK domains,
using replica-exchange Monte Carlo simulations integrated
in Domain Enhanced Modeling server (Zhou et al., 2019).
A protein-protein docking using ClusPro (Vajda et al., 2017)
was performed to ensure the optimum quality of the dual
domain homology model.
Once the quaternary structure of the enzyme was defined,
the linker sequence combining both monomers was determined
by support vector machine (SVM) implemented in Domain
linker pRediction using OPtimal features server (DROP)
(Ebina et al., 2011). Flexibility was calculated comparing the
atomic fluctuation of the loop with the rest of the structure
through molecular dynamic simulation (MD). To this end,
ZgHGPRT/AMPK model was complexed with Hyp, PRPP and
Mg2+ in the active site of the HGPRT domain, and with AMP,
ATP and Mg2+ in the active site of AMPK domain. The complex
was then immersed in a box of 10,500 TIP3P water molecules
that extended 15 Å away from any solute atom, and 20 Na+
ions were added to ensure electrical neutrality. Energy refinement
followed by unrestrained MD simulations for 30 ns were carried
out using the pmemd_cuda.SPFP module and the standard ff14SB
force field parameter set in AMBER16 (Case et al., 2016). Finally,
the cpptraj module (Roe and Cheatham, 2013) in AMBER16 was
employed for data processing of the calculated trajectories.
Analytical Methods
The production of nucleotides was measured quantitatively using
an ACE EXCEL (5 µm CN-ES 250 × 4.6 mm) equilibrated with
100% triethyl ammonium acetate at a flow rate of 0.8 mL/min.
Retention times for the reference natural compounds (hereafter
abbreviated according to the recommendations of the IUPAC-
IUB Commission on Biochemical Nomenclature) were as
follows: adenine (Ade), 10.4 min; adenosine-5′-monophosphate
(AMP), 5.5 min; adenosine-5′-diphosphate (ADP), 4.4 min;
adenosine-5′-triphosphate (ATP), 3.8 min; guanine (Gua),
4.8 min; guanosine-5′-monophosphate (GMP), 3.2 min;
hypoxanthine (Hyp), 4.5 min; inosine-5′- monophosphate
(IMP), 3.0 min; xanthine (Xan), 4.4 min; cytosine (Cyt),
3.9 min; uracil (Ura), 4.1 min; thymine (Thy), 7.2 min;
thymidine-5′-monophosphate (TMP), 4.4 min.
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FIGURE 4 | (A) Multiple sequence alignment of amino acid sequences of 6-oxopurine PRTs from Zobellia galactanivorans (ZgHGPRT/AMPK), Leptospira interrogans
(LiHGXPRT, PDB id 4QRI), Trypanosoma cruzi (TcHPRT, PDB id 1P19), Bacillus anthracis (BaHPRT, PDB id 6D9Q), Salmonella typhimurium (StHPRT, PDB id 1J7J),
Escherichia coli (EcHPRT, PDB id 5KNR), (B) Overall representation of the active site architecture of ZgHGPRT domain based on the structural alignment of
ZgHGPRT/AMPK homology model (green) with Trypanosoma cruzi HRPT (gray) complexed with PRPP and 7-hydroxypyrazolo[4,3-D]pyrimidine (PDB id 1TC2)
(sticks), and Mg2+ (black sphere). PRPP binding site, PPi and flexible loops (blue) and purine pocket (violet) are encircled with dotted lines. The figure was prepared




The genomic information of Zobellia galactanivorans has been
analyzed and published online (NC_015844.1). After an in silico
mining, we discovered an ORF that potentially encodes a putative
HGPRT/AMPK bifunctional protein annotated throughout the
genome. To confirm this, a bioinformatic analysis was performed.
The pairwise amino acid sequence alignment using BLASTP1
against Protein Data Bank revealed the presence of both
1http://blast.ncbi.nlm.nih.gov/Blast.cgi
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FIGURE 5 | (A) Multiple sequence alignment of amino acid sequences of AMPK from Zobellia galactanivorans (ZgHGPRT/AMPK), Aquifex aeolicus (AaAMPK, PDB
id 2RGX), Mycobacterium tuberculosis (MtAMPK, PDB id 1P4S), Geobacillus stearothermophilus (GsAMPK, PDB id 1ZIN), Marinibacillus marinus (MmAMPK, PDB
id 3FB4), Sporosarcina globispora (SgAMPK, PDB id 5X6J). (B) Overall representation of the active site architecture of ZgAMPK domain based on the structural
alignment of ZgHGPRT/AMPK homology model with AMPK from Homo sapiens (gray) complexed with P1,P4-Bis(5′-adenosyl) tetraphosphate (PDB id 2C95)
(sticks). P-Loop site (red), AMP binding site (blue) and LID domain (yellow) are encircled with dotted lines. The core domain (green), including P-loop site and AMPK
fingerprint, is also shown. The figure was prepared with PyMOL (Delano, 2002).
canonical, PRT and adenylate kinase domains, encoded in the
amino acid sequence (Figure 2). In this sense, with the aim
to understand these unusual sequence features, a 3D homology
model of ZgHGPRT/AMPK was built (Figures 2, 3).
According to the multiple sequence alignment of amino acid
sequences of closest PRT homologs, ZgHGPRT/AMPK would
belong to class I PRTs, which display a conserved 13-residue
“fingerprint” region (PRPP binding-motif) in their amino acid
sequence (Del Arco and Fernández-Lucas, 2017; Figure 4A).
Type I PRTs commonly display a core region composed by four-
or five-stranded parallel β-sheet surrounded by three α-helices
and a hood domain that completes the active site architecture,
and is also involved in nucleobase binding (Figure 4B). Some of
these catalytic residues are located in several flexible and highly
mobile loops which adopt different conformations depending on
the binding of substrates or products (Figure 4B). As shown in
Figure 4, some essential elements of type I PRTs architecture
were found in ZgHGPRT/AMPK amino acid sequence such as
PPi loop, the flexible loop and PRPP binding domain (including
PRPP loop), as well as in the homology model. Finally, the
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well-known purine pocket of purine PRTs was also found in
ZgHGPRT/AMPK amino acid sequence.
Regarding to the AMPK domain, the typical adenylate kinase
motifs are present in ZgHGPRT/AMPK amino acid sequence
(Figure 5A): (i) the P-loop (also known as Walker A motif),
that adopts a specific loop shape allowing the accommodation of
phosphate moiety from ATP, (ii) the AMP binding domain, which
ensures that the adenine group from adenylate is selectively
distinguished from other nitrogenous bases, and (iii) the LID
domain, which displays high mobility allowing the active
site isolation and thus generates a hydrophobic environment,
avoiding the hydrolysis and promoting phosphotransferase
activity (Formoso et al., 2015; Figure 5A). Moreover, AMPK
proteins have a α/β structure formed by 5 β-sheet surrounded
by several a-helices (Mukhopadhyay et al., 2010; Figure 5B).
Like other AMPKs, ZgHGPRT/AMPK shows the typical core
domain formed by the P-loop and a high conserved 12-residue
AMPK “fingerprint,” including the G-F-P-R sequence that
contribute to the protein folding and stabilization (Figure 5B;
Mukhopadhyay et al., 2010). As inferred from Figure 5B, ATP
would be located between the core and LID domains, while AMP
would be sandwiched between the core and the AMP binding
site (Figure 5B).
To form the complete monomer of the protein, both HGPRT
and AMPK domains are connected by an interdomain linker
consisting of 10 amino acids (REVYQLNQKH). This sequence
is characterized by charged and polar uncharged amino acids,
similar to other linkers from multidomain proteins (Argos, 1990;
George and Heringa, 2002). Moreover, this region displays a
coil secondary structure (Figure 2) with lower flexibility than
the average of the rest of the protein. However, certain degree
of flexibility is required to retain the function of individual
domains and to allow crucial domain interactions (Reddy
Chichili et al., 2013). Nevertheless, Arg, Glu, and Gln residues
present in the linker act as rigid spacers to prevent unfavorable
interactions between both domains (Chen et al., 2013). Finally,
as concluded from the protein-protein docking, multidomain
monomers are combined into a dimeric state, which corresponds
to the biologically active form of the enzyme (Figure 3).
Production and Purification of
ZgHGPRT/AMPK
The bioinformatics analysis of Zobellia galactanivorans genome
(NCBI reference sequence NC_015844.1) displayed the presence
of a putative ZgHGPRT/AMPK. The putative hgprt/ampk gene
from Zobellia galactanivorans was cloned and overexpressed
in E. coli BL21(DE3) as described above. The recombinant
N-terminal His6-tagged ZgHGPRT/AMPK was purified by an
affinity and an exclusion size chromatographic procedure. SDS-
PAGE analysis of the purified enzyme shows only one protein
band with an apparent molecular mass around 42 kDa (Figure 6).
The sedimentation velocity experiments revealed
ZgHGPRT/AMPK as a group of two species with an experimental
sedimentation coefficient of 4.51 S (s20,w = 4.55 S) (97%) and
7.10 S (s20,w = 7.23 S) (3%). The major species found in solution
corresponds to a dimer state (Mw = 83.33 kDa) and is compatible
FIGURE 6 | SDS-PAGE analysis of soluble ZgHGPRT/AMPK. Lane 1.
Precision Plus ProteinTM prestained standard from Bio-Rad used as a
molecular weight marker. Lane 2. Supernatant obtained after centrifugation of
the lysed cells. Lane 3. Pellet obtained after centrifugation of the lysed cells.
Lane 4. ZgHGPRT/AMPK (15 µg protein) after chromatography purification.
with a monomer subunit of 41.65 kDa, a molecular mass
similar to that calculated from the amino acid sequence of the
His6-tagged protein (43.77 kDa). Since ZgHGPRT/AMPK is the
first dual domain PRT/AMPK protein, there are not previous
examples to compare it with. However, different oligomeric
states have been described for 6-oxopurine PRTs from several
sources, such as dimeric 6-oxo PRTs from Sulfolobus solfataricus
(SsHGXPRT) and GPRT from Giardia lamblia (GlGPRT),
tetrameric 6-oxo PRTs from Thermus thermophilus (TtHGXPRT
and TtXPRT), Toxoplasma gondii (TgHGPRT) and E. coli
(EcXGPRT and EcHPRT), or the hexameric HGPRT from
Pyrococcus horikoshii (PfHGXPRT) (Del Arco and Fernández-
Lucas, 2017). In this respect it seems that ZgHGPRT/AMPK
could belong to dimeric 6-oxo PRTs.
Regarding to AMPKs, they are generally found in two
distinct oligomeric states, the trimeric class commonly present
in Archaea, and monomeric class more common in Eubacteria
(Davlieva and Shamoo, 2010).
Temperature and pH Dependence of
ZgHGPRT/AMPK Activity
The effect of temperature and pH on ZgHGPRT/AMPK activity
is shown in Figure 7A. ZgHGPRT/AMPK displays high activity
(>70%) across a broad temperature range (from 30 to 80◦C), with
a maximum at 50–60◦C, which is higher than those reported for
other mesophilic HGPRTs, such as HGXPRT from Plasmodium
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falciparum (T = 22◦C) (Mbewe et al., 2007), human HGPRT
(T = 22◦C) (Raman et al., 2004) or HPRT from Trypanosoma
cruzi (T = 37◦C) (Wenck et al., 2004).
Moreover, the pH profile revealed that ZgHGPRT/AMPK
displays high activity in a narrow pH range 6–7, with a
maximum peak when it was incubated in 50 mM sodium
phosphate pH 7 (Figure 7B). In addition, experimental data
suggest a strong dependence on the nature of buffer solution for
ZgHGPRT/AMPK.
Thermal Stability of ZgHGPRT/AMPK
ZgHGPRT/AMPK does not undergo any loss of activity when
stored at 4◦C in 20 mM sodium phosphate buffer, pH 7 for
365 days. However, a significant loss of activity (≈30%) was
observed when stored at −80◦C. Furthermore, the effect of
temperature on enzyme stability was evaluated by incubating
ZgHGPRT/AMPK for 4 h in 20 mM sodium phosphate pH 7,
in the temperature range 40–60◦C (Figure 8A). As expected for
a mesophilic enzyme, ZgHGPRT/AMPK suffered a high loss of
activity when incubated at 50 and 60◦C in a brief period of
time (relative activity <70% for incubation periods longer than
10 min). In contrast, ZgHGPRT/AMPK displayed a high relative
activity (around 80%) when stored at 40◦C for 240 min. These
results agree with thermal denaturation curves, which allowed
us to estimate a moderate melting temperature (Tm) of 45.25◦C
(Figure 8B). As shown in literature, the oligomerization state
of the 6-oxopurine PRTs may contribute to the overall stability
of the protein and high aggregation states favors the increase of
FIGURE 7 | Biochemical characterization of ZgHGPRT/AMPK. (A) Effect of temperature on ZgHGPRT/AMPK activity (•). (B) Effect of pH on ZgHGPRT/AMPK
activity, (•) 50 mM sodium citrate (pH 4–6), (◦) 50 mM MES (pH 5.5–7), () 50 mM sodium phosphate (pH 6–8.5), (M) 50 mM Tris–HCl (pH 7–9), (N) 50 mM sodium
borate (pH 8–11). All determinations were carried out in triplicate and the maximum standard deviation value was 2%.
FIGURE 8 | (A) Thermal inactivation of ZgHGPRT/AMPK at () 40◦C, (◦) 50◦C and (•) 60◦C. (B) Melting temperature of ZgHGPRT/AMPK. All determinations were
carried out in triplicate and the maximum standard deviation value was 1.8%.
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FIGURE 9 | Influence of divalent salts on ZgHGPRT/AMPK activity. (•) MgSO4,
(◦) CoSO4, (M) MgSO4, (N) ZnSO4 and () CaCl2. All determinations were
carried out in triplicate and the maximum standard deviation value was 1.7%.
thermal stability in 6-oxo PRTs (Del Arco and Fernández-Lucas,
2017). Considering the dimeric nature of ZgHGPRT/AMPK, a
high thermal stability was not expected in this case.
Effect of Divalent Cations on Enzyme
Activity
Once optimal conditions of pH (7) and temperature (50◦C) were
stablished, the effect of divalent cations on enzyme activity was
assayed (Figure 9). As described for HGPRTs, the presence of two
divalent metal ions in the active site of these enzymes is crucial
for the catalytic reaction. In fact, they are associated with both
the PPi of PRPP and with active site residues (directly or through
water molecules). One of these cations is also linked to the purine
base through a water molecule, placing the purine substrate for
catalysis (Sinha and Smith, 2001).
As expected, an absolute requirement for divalent cations
was observed. Thus, the optimum concentration of cations was
stablished in a range of 2–3 mM, obtaining best activity values
with Mg2+ 2 mM. Since high activity values were also observed
when using Mn2+, it might act as an effective substitute for
Mg2+, as also described for other HGPRTs such as those from
E. coli, Salmonella typhimurium (Hochstadt, 1978), Artemia sp.
(Montero and Llorente, 1991) and yeast (Ali and Sloan, 1986).
Similar to Artemia sp. (Montero and Llorente, 1991) and yeast
(Ali and Sloan, 1986), Zn2+ can also activate the phosphoribosyl
activity on ZgHGPRT, although to a lesser extent than Mg2+.
As shown in Figure 6, high activity values were also obtained
with Co2+, which is consistent with yeast HGPRT (Ali and Sloan,
1986). Finally, significant low activity values were obtained when
using Ca2+, so it could not replace Mg2+ as observed for HGPRT
from Plasmodium falciparum (Mbewe et al., 2007). This finding
also suggests that Ca2+ might act as an inhibitor, as described for
APRT from Artemia sp. (Montero and Llorente, 1991).
Effect of Organic Solvents on
ZgHGPRT/AMPK Activity
To investigate the effect of organic solvents on enzyme activity,
phosphoribosyltransferase activity was assayed in the presence
of 20% (v/v) polar protic (MeOH, EtOH, isopropanol, glycerol,
ethylene glycol, and propylene glycol) and aprotic co-solvents
(acetonitrile, acetone, chloroform, N,N-dimethylformamide,
DMSO and ethyl acetate) (Fernández-Lucas et al., 2012; Del Arco
et al., 2018d). As shown in Figure 10, there is a negligible loss
of activity (less than 5%) in presence of 20% glycerol, ethylene
glycol, chloroform and ethyl acetate. A moderate loss of activity
(less than 40%) was observed in presence of 20% acetonitrile,
DMSO, MeOH, EtOH, and propylene glycol. Finally, a significant
FIGURE 10 | Effect of organic co-solvents (20% v/v) on ZgHGPRT/AMPK activity. (A) Aprotic polar solvents. (B) Alcohols and polyols. All determinations were
carried out in triplicate and the maximum standard deviation value was 2%.
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TABLE 1 | Effect of 20% of organic co-solvents on ZgHGPRT/AMPK activity.
Solvent Relative activity (%) Log P ε
Aprotic co-solvents
Ethyl acetate 100 0.73 6.0
Chloroform (non-miscible) 96 1.83 4.8
Acetone 51 −0.21 21
Acetonitrile 62 −0.3 36.6
DMF 53 −1.0 38.25
DMSO 63 −1.3 47.24
Protic co-solvents
Glycerol 100 −3.03 47
Ethylene glycol 100 −1.80 37
Propylene glycol 85 −0.64 32
EtOH 72 −0.24 25
MeOH 62 −0.76 32.7
Isopropanol 49 0.05 20
Reaction conditions were 6.5 µg of enzyme in 40 µl at 50◦C for 10 min, in presence
of 20% organic co-solvents. Substrate concentrations were 2 mM PRPP, 2 mM
Hyp, 2.4 mM MgCl2 in 50 mM sodium phosphate buffer, pH 7.
loss of activity is observed when acetone, DMF or isopropanol
were added to the reaction mixture.
A correlation between hydrophobicity and activity
(Figure 10A) was observed when using aprotic co-solvents.
In this respect, the highest activity values are shown in the
presence of 20% of hydrophobic solvents (log P > 0), such
as ethyl acetate (100% relative activity, log P = 0.73) or
chloroform (non-miscible solvent, 95.6% relative activity, log
P = 1.83), whereas a significant activity decrease is observed
for hydrophilic solvents (log P value < 0), such as acetone
(51% relative activity, log P = −0.21), acetonitrile (62%
relative activity, log P = −0.3), DMF (53% relative activity,
log P = −1.0), DMSO (63% relative activity, log P = −1.3)
(Table 1). Moreover, we also observe an increase of enzymatic
activity when the dielectric constant (ε) decreases, displaying the
highest activity values for ethyl acetate (ε = 6.0) and chloroform
(ε = 4.8), and the lowest values for DMF (ε = 38) and acetone
(ε = 21) (Table 1).
The increase of enzymatic activity in the presence of
20% protic solvents (mono alcohols and polyols) seems
to be linked to the increase of dielectric constant (ε),
in the following order: glycerol (ε = 47) > ethylene
glycol (ε = 37) > propylene glycol (ε = 32) ≈ MeOH
(ε = 32.7) > EtOH (ε = 25) > isopropanol (ε = 20)
(Figure 10B and Table 1). However, higher relative activities
were obtained for polyols (100–85%), instead of those
obtained for mono alcohols (72–49%), which indicates
that the size and/or conformation of polyols also affect the
enzyme activity.
FIGURE 11 | Structural alignment of ZgHGPRT/AMPK model (green) and TtHGXPRT (yellow) complexed with IMP (atom-type coloring sticks). Hydrogen bonds
formed between the protein residues and IMP are shown as yellow dotted lines. Active site residues in the model are represented by sticks with the atom-type
coloring (green). The figure was prepared with PyMOL (Delano, 2002).
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TABLE 2 | Substrate specificity studies for ZgHGPRT/AMPK using different nucleotides and nucleobases as substrates.
Donor Acceptor Product 1 Specific activity (U/mg) Product 2 Specific activity (U/mg)
PRTase activity
PRPP Adea AMP n.d.
Cyta CMP n.d. − −
Guab GMP 0.47 ± 0.03 − −
Hypa IMP 0.53 ± 0.05 − −
Uraa UMP n.d. − −
Thya TMP n.d. − −
Xanb XMP n.d. − −
Kinase activity
ADP ADPc AMP 0.03 ± 0.004 ATP 0.03 ± 0.004
ATP AMPd ADP 0.09 ± 0.01 − −
aReaction conditions were 6.5 µg of enzyme in 40 µl at 50◦C for 10 min. Substrate concentrations were 2 mM PRPP, 2 mM base, 2.4 mM MgCl2 in 50 mM sodium
phosphate buffer, pH 7. bReaction conditions were 6.5 µg of enzyme in 40 µl at 50◦C for 10 min. Substrate concentrations were 2 mM PRPP, 2 mM base, 2.4 mM
MgCl2 in 50 mM Tris–HCl buffer, pH 8. cReaction conditions were 13 µg of enzyme in 40 µl at 50◦C for 10–20 min. Substrate concentrations were 6.4 mM ADP, 12 mM
MgCl2 in 50 mM sodium phosphate buffer, pH 7. dReaction conditions were 13 µg of enzyme in 40 µl at 50◦C for 10–20 min. Substrate concentrations were 3.2 mM
AMP, 3.2 mM ATP, 12 mM MgCl2 in 50 mM sodium phosphate buffer, pH 7.
TABLE 3 | Steady-state kinetic parameters for both IMP and ADP synthesis
catalyzed by ZgHGPRT/AMPK.
Parameter Value with variable substrate
Hypa PRPPb ATPc AMPd
KM (mM) 1.01 ± 0.05 6.77 ± 0.41 0.77 ± 0.04 8.02 ± 0.40
kcat (s−1) 1.11 ± 0.06 2.82 ± 0.21 0.07 ± 0.003 0.16 ± 0.008
kcat/KM 1.10 0.42 0.10 0.02
Ki (mM) 11.12 ± 1.02 – – –
aConcentration range 0.5–17.2 mM Hyp at a fixed PRPP concentration of 5 mM.
bConcentration range 0.5–17.2 mM PRPP at a fixed Hyp concentration of 5 mM.
cConcentration range 0.5–10 mM AMP at fixed ATP concentration of 3.2 mM.
dConcentration range 0.5–10 mM ATP at fixed AMP concentration of 3.2 mM.
Substrate Specificity
Table 2 summarizes specific activities of ZgHGPRT/AMPK for
both, phosphoribosyltransferase and adenylate kinase activities.
As expected for previous in silico analysis, ZgHGPRT/AMPK can
perform the phosphoribosyltransferase reaction on 6-oxopurines
(Hyp and Gua), while neither 6-aminopurines nor pyrimidine
bases are substrates for ZgHGPRT/AMPK. In addition, no
transferase reaction was observed when xanthine was used as
acceptor. These results agree with previous reports for purine
PRTs since, for the purine salvage, organisms usually display
different PRTs, one specific for adenine and one or more
responsible for the salvage of 6-oxopurines (Del Arco and
Fernández-Lucas, 2017). In this sense, the presence of an aprt
gene encoding a putative APRT (GenBank: CAZ96936.1) in
Zobellia galactanivorans genome would support our findings.
To explain these results, a homology model of
ZgHGPRT/AMPK was built (Figure 3), and then it was
superposed with HGXPRT from Thermus thermophilus HB8
complexed with IMP (TtHGXPRT, PDB id 3ACD) (Kanagawa
et al., 2010; Del Arco et al., 2017). As shown in Figure 11,
hypoxanthine binding is stabilized by a network of hydrogen
bonds between Asp 104, Lys 132 and Ile 154, and N1, exocyclic
O6 and N7 of the purine ring. Due to the absence of any suitable
residues for the recognition of exocyclic NH2, 6-aminopurines
are not properly accommodated for binding and catalysis.
Furthermore, ZgHGPRT/AMPK also catalyzed the
phosphotransfer reaction between adenine nucleotides. As
shown in Table 2, ZgHGPRT/AMPK is more active (up to 3
times) when transferring γ-phosphate moiety from ATP to
α-phosphate of AMP, than it is for the reverse reaction. In
this sense, the reaction equilibrium seems to be shifted toward
ADP synthesis. Moreover, the PRTase/kinase activity ratio is
around 5-6/1, which indicates a strong preference for Hyp and
PRPP instead of adenine nucleotides as substrates. These results
might suggest ZgHGPRT/AMPK plays a key role in salvage
pathway, whereas it is not essential for maintaining the cellular
homeostasis of adenine nucleotides.
The presence of the genes in Zobellia galactanivorans genome
coding other putative enzymes which could also be involved
in the metabolism of adenine nucleotides, such as an APRT
(GenBank: CAZ96936.1), a ribonucleotide reductase (GenBank:
CAZ95963.1), a nucleoside diphosphate kinase (GenBank:
CAZ97836.1) and adenylate cyclase (GenBank: CAZ95571.1),
would reinforce this hypothesis.
Kinetic Analysis
Steady-state kinetic studies were conducted at variable
concentrations of Hyp or PRPP to determine kinetic parameters
(KM, kcat, and kcat/KM). The results are summarized in Table 3.
ZgHGPRT/AMPK displays a lower KM value for Hyp than for
PRPP, which agrees with kinetic data described for other type
I PRTs (Munagala et al., 1998; Wenck et al., 2004; Kanagawa
et al., 2010). Moreover, a lower kcat, value is observed for Hyp,
which is lined with as apparent substrate inhibition at high Hyp
concentration (Table 3).
Regarding to the ADP synthesis, KM for AMP is 10-fold
higher than KM for ATP. This significant difference in the
affinity between AMP and ATP is probably due to a more
unstable binding of AMP onto AMP binding site, whereas the
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ATP binding onto LID domain seems to be favored (Zeller
and Zacharias, 2015). Moreover, the turnover numbers are in
compliance with the release form of products, where ADP
liberation from AMP occurs through AMP binding site, and ADP
liberation from ATP occurs through CORE domain (Zeller and
Zacharias, 2015). Finally, the difference in the catalytic efficiency
between AMP and ATP fits the model described by Ådén et al.
(2013) where AMP can bind to LID with a very low affinity
generating an unproductive complex (Whitford et al., 2007; Ådén
et al., 2013; Zeller and Zacharias, 2015).
CONCLUSION
Herein we report a novel bifunctional hypoxanthine-
guanine phosphoribosyltransferase (HGPRT)/adenylate kinase
(AMPK) from Zobellia galactanivorans (ZgHGPRT/AMPK).
ZgHGPRT/AMPK is the only two in one HGPRT/AMPK
described up to date. Experimental results revealed
ZgHGPRT/AMPK as a homodimer, active in the pH range 6–7
and in a temperature interval from 30 to 80◦C, and also displaying
a moderate thermal stability. More interestingly, substrate
specificity studies revealed ZgHGPRT/AMPK as a bifunctional
enzyme, which acts as phosphoribosyltransferase or adenylate
kinase depending upon the nature of substrates. Finally, the
kinetic analysis of both activities (phosphoribosyltransferase
and adenylate kinase), as well as the effect of divalent cations
and water-miscible solvents on enzyme activity, were described
for a suitable application as biocatalyst for the synthesis of
nucleoside-5′-mono, -di and triphosphates.
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